Company Profile
Azenta Life Sciences Stock Price, News & Analysis
- Ticker:
- AZTA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Azenta Life Sciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
22.20 USD (-0.31%)
Close
Last updated: June 23, 2026 at 00:00
1.02B USD
Market cap
Why the stock is moving
AZTA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Azenta Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Azenta Life Sciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Azenta Life Sciences follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Azenta Life Sciences sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
Source: Azenta Life Sciences
- 02
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
Source: Azenta Life Sciences
- 03
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
Source: Azenta Life Sciences
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Azenta Life Sciences (AZTA)?
Azenta Life Sciences (AZTA) most recently closed at 22.20 USD, a -0.31% move versus the previous session.
What is the market cap of Azenta Life Sciences (AZTA)?
Azenta Life Sciences currently has a market capitalization of 1.02B USD on BioPharmSignal.
What does Azenta Life Sciences do?
Azenta Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is AZTA stock listed?
Azenta Life Sciences (AZTA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Azenta Life Sciences is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Azenta?
Azenta Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Azenta Life Sciences targeting with Azenta?
Azenta Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Life?
Azenta Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Sciences?
Azenta Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.